NormOxys, Inc.
16 Laurel Avenue
Suite 150
Wellesley
Massachusetts
02481
United States
Tel: 339-686-7354
Fax: 339-686-7359
Website: http://www.normoxys.com/
5 articles about NormOxys, Inc.
-
NormOxys, Inc.' Novel Oxygen-Enhancing Drug Candidate, OXY111A, Recognized as One of Windhover Information Inc.'s Top 10 Cardiovascular/Metabolic Projects to Watch
11/3/2010
-
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
10/5/2010
-
NormOxys, Inc. Appoints Dr. John A. Hey Senior Vice President of Preclinical and Early Development
6/21/2010
-
NormOxys, Inc. Secures $17.5 Million Series B Financing to Advance Lead Drug Candidate into Clinical Studies for Two Diseases
5/24/2010
-
NormOxys, Inc. Initiates Phase 1 Clinical Trial of Allosteric Effector of Hemoglobin, OXY111A
5/24/2010